$117 Million is the total value of University of Massachusetts Foundation, Inc.'s 5 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | Buy | VANGUARD INDEX FDStotal stk mkt | $37,498,000 | +77.8% | 198,800 | +114.6% | 32.14% | +67.7% |
| IVV | Buy | ISHARES TRcore s&p500 etf | $33,628,000 | -9.8% | 88,692 | +7.9% | 28.83% | -14.9% |
| IEMG | Buy | ISHARES INCcore msci emkt | $28,835,000 | -10.6% | 587,750 | +1.2% | 24.72% | -15.7% |
| IEFA | Buy | ISHARES TRcore msci eafe | $16,565,000 | -13.4% | 281,481 | +2.3% | 14.20% | -18.4% |
| CLOV | Sell | CLOVER HEALTH INVESTMENTS CO | $128,000 | -48.6% | 59,640 | -14.9% | 0.11% | -51.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 16 | Q3 2023 | 52.3% |
| ISHARES INC | 16 | Q3 2023 | 48.5% |
| ISHARES TR | 16 | Q3 2023 | 43.2% |
| ISHARES TR | 10 | Q3 2023 | 35.1% |
| ISHARES TR | 4 | Q3 2020 | 14.7% |
| CLOVER HEALTH INVESTMENTS CO | 4 | Q2 2022 | 0.5% |
| ISHARES TR | 1 | Q1 2020 | 19.4% |
| ISHARES TR | 1 | Q1 2020 | 9.4% |
| PALANTIR TECHNOLOGIES INC | 1 | Q1 2021 | 0.5% |
View University of Massachusetts Foundation, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-10-31 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-10 |
| 13F-HR/A | 2023-02-13 |
| 13F-HR | 2023-01-24 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
View University of Massachusetts Foundation, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.